Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2009; 101(05): 983-985
DOI: 10.1160/TH08-12-0798
DOI: 10.1160/TH08-12-0798
Letters to the Editor
Endothelial progenitor cells are selectively mobilised immediately after coronary artery bypass grafting or valve surgery
Further Information
Publication History
Received:
08 December 2008
Accepted after major revision:
30 January 2009
Publication Date:
24 November 2017 (online)
-
References
- 1 Smadja DM, Cornet A, Emmerich J. et al. Endothelial progenitor cells: Characterization, in vitro expansion, and prospects for autologous cell therapy. Cell Biol Toxicol 2007; 23: 223-239.
- 2 Hill JM, Zalos G, Halcox JP. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
- 3 Hristov M, Zernecke A, Liehn EA. et al. Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost 2007; 98: 274-277.
- 4 Ergun S, Tilki D, Hohn HP. et al. Potential implications of vascular wall resident endothelial progenitor cells. Thromb Haemost 2007; 98: 930-939.
- 5 Scheubel RJ, Zorn H, Silber RE. et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073-2080.
- 6 Gill M, Dias S, Hattori K. et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001; 88: 167-174.
- 7 Roberts N, Xiao Q, Weir G. et al. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 2007; 83: 598-605.
- 8 Ruel M, Suuronen EJ, Song J. et al. Effects of off-pump versus on-pump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells. J Thorac Cardiovasc Surg 2005; 130: 633-639.
- 9 Mieno S, Ramlawi B, Boodhwani M. et al. Role of stromal-derived factor-1alpha in the induction of circulating CD34+CXCR4+ progenitor cells after cardiac surgery. Circulation 2006; 114 (Suppl. 01) I186-192.
- 10 Cesari F, Caporale R, Marcucci R. et al. NTproBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells’ response to cardiac surgery. Atherosclerosis 2008; 199: 138-146.
- 11 Van Craenenbroeck EM, Conraads VM, Van Bockstaele DR. et al. Quantification of circulating endothelial progenitor cells: A methodological comparison of six flow cytometric approaches. J Immunol Methods 2008; 332: 31-40.
- 12 Smadja DM, Bieche I, Silvestre JS. et al. Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol 2008; 28: 2137-2143.
- 13 Smadja DM, Gaussem P, Mauge L. et al. Circulating endothelial cells. A new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation. 2009 in press.
- 14 Smadja DM, Bieche I, Susen S. et al. Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. J Cell Mol Med. 2009 in press.
- 15 Kissel CK, Lehmann R, Assmus B. et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 2007; 49: 2341-2349.
- 16 Yang C, Zhang ZH, Li ZJ. et al. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb Haemost 2004; 91: 1202-1212.
- 17 Delorme B, Basire A, Gentile C. et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 2005; 94: 1270-1279.
- 18 George J, Shmilovich H, Deutsch V. et al. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 2006; 12: 331-335.
- 19 Leone AM, Rutella S, Bonanno G. et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005; 26: 1196-1204.
- 20 Schmidt-Lucke C, Rossig L, Fichtlscherer S. et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987.
- 21 Werner N, Kosiol S, Schiegl T. et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
- 22 Sturiale A, Coppolino G, Loddo S. et al. Effects of haemodialysis on circulating endothelial progenitor cell count. Blood Purif 2007; 25: 242-251.
- 23 Herbrig K, Pistrosch F, Oelschlaegel U. et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004; 44: 840-849.
- 24 Redondo S, Hristov M, Gumbel D. et al. Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1. Thromb Haemost 2007; 97: 979-987.
- 25 Hristov M, Fach C, Becker C. et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 2007; 192: 413-420.
- 26 Deschaseaux F, Selmani Z, Falcoz PE. et al. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur J Pharmacol 2007; 562: 111-118.
- 27 Strehlow K, Werner N, Berweiler J. et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003; 107: 3059-3065.
- 28 Fadini GP, de Kreutzenberg S, Albiero M. et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008; 28: 997-1004.
- 29 Di Stefano R, Barsotti MC, Melillo E. et al. The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia. Thromb Haemost 2008; 100: 871-877.